NCT05512546View on ClinicalTrials.gov

The Prevention of Thromboembolic Complications Associated With Coil Embolization

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 10, 2017

Primary Completion Date

February 10, 2020

Study Completion Date

December 10, 2020

Conditions
Thromboembolic StrokeAspirinClopidogrelCoil EmbolizationPrevention
Interventions
DRUG

Aspir-Low Pill

patients were prescribed 75 mg/day of either aspirin

Trial Locations (1)

54000

Umair Rasheed, Lahore

All Listed Sponsors
lead

Muhammad Hassan

OTHER

NCT05512546 - The Prevention of Thromboembolic Complications Associated With Coil Embolization | Biotech Hunter | Biotech Hunter